Markel Group (NYSE: MKL) director files Form 4 for planned stock sales

Rhea-AI Filing Summary

Markel Group Inc. director Steven A. Markel reported small open-market sales of company stock. On 11/26/2025, he sold 70 shares of Markel Group common stock at a price of $2,100 per share, and on 11/28/2025 he sold an additional 100 shares at $2,100 per share, both coded as sales. These transactions were executed under a Rule 10b5-1 trading plan adopted on August 15, 2025, which pre-schedules trades to help avoid trading on inside information.

After these sales, Steven A. Markel directly owned 61,698 shares of Markel Group common stock. In addition, he had 2,060.699 shares held indirectly through the MKL 401(k) plan, based on the plan balance as of September 30, 2025, and 15,000 shares reported as held indirectly by his spouse, for which beneficial ownership is expressly disclaimed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MARKEL STEVEN A

(Last) (First) (Middle)

C/O MARKEL GROUP INC.

4521 HIGHWOODS PARKWAY

(Street)

GLEN ALLEN VA 23060

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARKEL GROUP INC. [ MKL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/26/2025		S		70	D	$2,100	61,798	D(1)
Common Stock	11/28/2025		S		100	D	$2,100	61,698	D(1)
Common Stock								2,060.699	I	401(K) Plan(2)
Common Stock								15,000	I	By Spouse(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted August 15, 2025.

2. The information reported herein is based on the MKL 401(k) plan balance as of September 30, 2025.

3. Beneficial ownership of securities is expressly disclaimed.

Remarks:

	/s/ Sarah T. Mikowski, Attorney-in-fact for Steven A. Markel	12/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Markel Group (MKL) report in this Form 4?

The filing shows that director Steven A. Markel sold 70 shares of Markel Group common stock on 11/26/2025 and 100 shares on 11/28/2025, with both transactions reported as open-market sales.

At what price did Steven A. Markel sell his Markel Group (MKL) shares?

Both reported sales were executed at a price of $2,100 per share for Markel Group common stock.

How many Markel Group (MKL) shares does Steven A. Markel own after the reported trades?

Following the reported transactions, Steven A. Markel directly owned 61,698 shares of Markel Group common stock, with additional indirect holdings through a 401(k) plan and by his spouse.

What indirect Markel Group (MKL) holdings are reported for Steven A. Markel?

The filing reports 2,060.699 shares of Markel Group common stock held indirectly in the MKL 401(k) plan, based on the balance as of September 30, 2025, and 15,000 shares held indirectly by his spouse, for which beneficial ownership is expressly disclaimed.

Were the Markel Group (MKL) stock sales made under a Rule 10b5-1 plan?

Yes. The explanation states that the reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted on August 15, 2025.

What is Steven A. Markel’s role at Markel Group (MKL)?

In this filing, Steven A. Markel is identified as a director of Markel Group Inc.